[1] J.R. Jaglowski and B.C. Jr. Stack. Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin, Cancer Lett, 243 (1) (2006) 58–63.
[2] E.C. Halperin, L.W. Brady, C.A. Perez and D.E. Wazer. Perez and Brady’s Principles and Practice of Radiation Oncology, 60 (2018) 44–49.
[4] V. Voigts-Rhetz, M. Anton, H. Vorwerk and K. Zink. Perturbation Correction for Alanine Dosimeters in Different Phantom Materials in High-Energy Photon Beams, Phys. Med. Bio, 61(3) (2016) 70–79.
[6] Y. Zhao, G. Qi, G. Yin, X. Wang, P. Wang, J. Li, M. Xiao, J.I. Li, S. Kang and X. Liao. A clinical study of lung cancer dose calculation accuracy with Monte Carlo simulation, Radiation Oncology, (2014) 9:287.
[7] N. Kavousi, H.A. Nedai, S. Gholami, M. Esfahani and G. Geraili. Evaluation of Dose Calculation Algorithms Accuracy for Eclipse, PCRT3D, and Monaco Treatment Planning Systems Using IAEA TPS commissioning tests in a Heterogeneous Phantom, ran J Med Phys, (2019) 16: 285–293.
[8] S.H. Babazadeh, A.R. Andalib, H. Emami, J. Emami, T. Azarm, F. Mokarian and M. Tazhibi. Epidemiology of cancers in Isfahan province: A retrospective study, Journal of Research in Medical Sciences, 2(5) (2000) 127-135.